TSE:GEN

GeneNews Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume473,147 shs

Average Volume1.48 million shs

Market CapitalizationC$25.49 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive GEN News and Ratings via Email

Sign-up to receive the latest news and ratings for GeneNews and its competitors with MarketBeat's FREE daily newsletter.

About GeneNews

GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. GeneNews Limited was founded in 1998 and is headquartered in Richmond Hill, Canada.

In-Vitro Colorectal Cancer Screening Tests Market Share, Size to register significant growth over 2017-2024 - Industry Analysis
March 8, 2021 | marketwatch.com

Global Colorectal Cancer Diagnostic Market 2020 Industry Size, Segments, Share, Key Players and Growth Factor Analysis by 2025
September 21, 2020 | marketwatch.com

Blood Cancer Diagnostics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
September 16, 2020 | marketwatch.com

In-Vitro Colorectal Cancer Screening Tests Market Share, Trend and Size to register significant growth over 2018-2024
August 3, 2020 | www.marketwatch.com

New Report: In-Vitro Colorectal Cancer Screening Tests Market Share, Trend and Size to register significant growth over 2017-2024
August 3, 2020 | www.marketwatch.com

GeneNews' Innovative Diagnostic Laboratory Appoints David Byram Chief Commercial Officer
May 20, 2020 | www.bloomberg.com

GeneNews Announces Q1-2017 Financial Results & Provides Progress Update
May 16, 2020 | www.bloomberg.com

GeneNews Announces Q2 2018 Results and Provides Progress Update
May 11, 2020 | www.bloomberg.com

Global Colorectal Cancer Diagnostic Market 2020 Definition, Size, Classifications, Applications and Forecast data by 2026
April 16, 2020 | www.marketwatch.com

Central Nervous System (CNS) Therapeutic Market Analysis 2018 by Share Trends, Leading Key Players, Future Growth, Revenue, Demand Forecast To 2028
April 3, 2020 | www.marketwatch.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange TSE
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolTSE:GEN
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.genenews.com
Phone+1-905-7392030
Employees15
Year FoundedN/A

Sales & Book Value

Annual SalesC$234,592.00
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow145.00
Book ValueC($0.06) per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares169,963,000
Market CapC$25.49 million
Next Earnings DateN/A
OptionableOptionable

MarketRank^™

Overall MarketRank^™

0.88 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for GeneNews.

4.4 Community Rank

Outperform Votes
GeneNews has received 88 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
GeneNews has received 46 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
GeneNews has received 65.67% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about GeneNews and other stocks. Vote “Outperform” if you believe GEN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GEN will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
GeneNews does not currently pay a dividend.
Dividend Growth
GeneNews does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, GeneNews insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of GeneNews is -2.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of GeneNews is -2.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

GeneNews (TSE:GEN) Frequently Asked Questions

What stocks does MarketBeat like better than GeneNews?

Wall Street analysts have given GeneNews a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but GeneNews wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are GeneNews' key executives?

GeneNews' management team includes the following people:

Mr. James R. Howard-Tripp, Exec. Chairman & CEO
Ms. Joanna M. Halsey Esq., Gen. Counsel, Chief Compliance Officer & HR Director of IDL
Prof. Choong-Chin Liew Ph.D., Co-Founder
Mr. Warren Whitehead, Chief Accountant (Age 67)
Mr. David Suria, Sr. Scientist

Who are some of GeneNews' key competitors?

Some companies that are related to GeneNews include Yourgene Health (YGEN), SQI Diagnostics (SQD), LexaGene (LXG), Cambridge Cognition (COG), VentriPoint Diagnostics (VPT), Abingdon Health (ABDX), genedrive (GDR), LED Medical Diagnostics (LMD), Deepmatter Group (DMTR), Imaging Dynamics (IDL), Integrated Diagnostics (IDHC), 3D Signatures (DXD), Med Biogene (MBI), (BUX) (BUX) and Australian Clinical Labs (ACL).
View all of GEN's competitors.

What other stocks do shareholders of GeneNews own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GeneNews investors own include StorageVault Canada (SVI), AmerisourceBergen (ABC), American Airlines Group (AAL), Aareal Bank (ARL), (ATE), Broadcom (AVGO), Aspen Technology (AZPN), British American Tobacco (BATS), Cronos Group (CRON) and Edwards Lifesciences (EW).

What is GeneNews' stock symbol?

GeneNews trades on the Toronto Stock Exchange (TSX) under the ticker symbol "GEN."

How do I buy shares of GeneNews?

Shares of GEN and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

How much money does GeneNews make?

GeneNews has a market capitalization of C$0.00 and generates C$234,592.00 in revenue each year.

How many employees does GeneNews have?

GeneNews employs 15 workers across the globe.

What is GeneNews' official website?

The official website for GeneNews is www.genenews.com.

Where are GeneNews' headquarters?

GeneNews is headquartered at 445 Apple Creek Blvd Unit 220, MARKHAM, ON L3R 9X7, Canada.

How can I contact GeneNews?

GeneNews' mailing address is 445 Apple Creek Blvd Unit 220, MARKHAM, ON L3R 9X7, Canada. The company can be reached via phone at +1-905-7392030.

This page was last updated on 8/1/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

GeneNews Stock Forecast, Price & News

About GeneNews

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

4.4 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth